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Background and purpose   Autonomic neuropeptide Y (NPY) is 
involved in local bone remodeling via the central nervous system. 
However, the role of peripheral neuronal NPY in fracture healing 
is not known. We investigated the relationship between bone heal-
ing and side-specific occurrence of NPY in angular and straight 
fractures. 
Methods   Tibial fractures in Sprague-Dawley rats were fixed 
with  intramedullary  pins  in  straight  alignment  and  anterior 
angulation. The samples were analyzed by radiography, histol-
ogy, and immunohistochemistry (IHC) between 3 and 56 days 
postfracture.
Results   In the angular fractures, radiography and histology 
showed a 3.5-fold increase in callus thickness on the concave side 
compared to the convex side at day 21, whereas a 0.2-fold reduc-
tion in callus thickness was seen on the convex side between days 
21 and 56. IHC showed regenerating NPY fibers in the callus and 
woven bone in both fractures at day 7. In angular fractures, a 
5-fold increase in NPY fibers was observed on the concave side 
compared to the convex side at 7 days, whereas a 6-fold increase 
in NPY fibers was seen on the convex side between 21 and 56 days; 
only a 0.1-fold increase in NPY fibers was seen on the concave side 
during the same time period. In straight fractures, similar bony 
and neuronal changes were observed on both sides. 
Interpretation   The increase in NPY innervation on the convex 
side appears to correlate with the loss of callus thickness on the 
same side in angular fractures. Our results highlight the probable 
function of the peripheral NPY system in local bone remodeling.
 
The  ability  of  bone  to  maintain  its  structures  and  proper-
ties or to remodel after trauma under different conditions is 
well known, but the underlying neurobiological mechanisms 
are poorly understood. The bone has a rich supply of nerve 
fibers, which can be classified as belonging to the sensory, 
autonomic, and opioid nervous systems according to the phe-
notype of the neurotransmitters (Bjurholm et al. 1988, Hill et 
al. 1991). This strongly supports the peripheral role of neu-
ropeptides in bone physiology. Recently, the role of neural 
signaling by the central nervous system in bone remodeling 
through various pathways has been given some attention. One 
such pathway is the neuropeptide Y (NPY) system. NPY, a 
36 amino acid peptide, belongs to a class of peptides that 
includes pancreatic polypeptide (PP) and peptide-YY (PYY), 
which are expressed in the central and peripheral autonomic 
nervous system. This system signals through 5 distinct recep-
tors (Y1, Y2, Y4, Y5, and Y6) expressed in various tissues. 
NPY has several functions: among these are effects on energy 
homeostasis, food intake, immunity, and the cardiovascular 
system (Lin et al. 2004). Recently, an important role of NPY 
in bone homeostasis has been identified through its effect 
on Y2 and Y1 receptors: a study in mice with hypothalamic 
deletion of Y2 receptors showed a generalized increase in 
bone formation (Baldock et al. 2002). In contrast to this cen-
tral action of Y2 receptors, the presence of Y1 receptors on 
osteoblasts suggests a direct local effect on these cells (Lun-
dberg et al. 2007). It has been shown that mice deficient in 
Y1 receptors have a high bone mass (Baldock et al. 2007). 
Whether it occurs through NPY-ergic pathways emanating 
from the hypothalamus or through skeletal NPY innervation 
has not been determined. 
In the bone, NPY-immunoreactive fibers have been identi-
fied in areas of high osteogenic potential such as bone marrow 
and the periosteum (Bjurholm et al. 1988, Hill et al. 1991). 
These nerve fibers were found to be arranged as networks, 
mainly around blood vessels. Experimental studies in vivo 
have shown that NPY acts as a potent vasoconstrictor of blood 
vessels in bone (Lindblad et al. 1994), but its role in local bone 
turnover is not clear. Moreover, under conditions of trauma it 
is not known whether NPY participates in different biological 
events such as inflammation, cell proliferation, angiogenesis, 
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Recently, we reported a rat model of angulated tibial fracture 
that showed side-specific changes in bone formation on the 
concave side and bone resorption on the convex side of defor-
mities in the same bone (Li et al. 2004, 2007). The process 
of bone formation/resorption in this animal model, leading to 
bone healing and remodeling, might be affected by peripheral 
expression of NPY because of its role in skeletal homeostasis. 
We therefore assessed the temporal and side-specific expres-
sion of NPY at the fracture site during healing and remodeling 
by morphological and semiquantitative analysis using immu-
nohistochemistry.
Materials and methods 
44 male Sprague-Dawley rats with a mean weight of 200 g 
were housed 3 per cage with free access to standard rat chow 
and water under controlled temperature and a 12-hour light/
dark  cycle.  All  animal  experiments  were  performed  with 
approval from the Ethics Committee for Animal Research, 
Stockholm  North.  The  rats  were  allocated  to  3  groups  as 
follows: 20 rats with a tibial fracture in anterior angulation 
(group A); 20 rats with a tibial fracture in straight alignment 
(group B); and 4 control rats with intact tibia (group C). 
Surgery 
The rats were anesthetized with an intraperitoneal (i.p.) injec-
tion of fentanyl-fluanisone (Hypnorm, 0.5 mL/kg). The right 
tibia was first weakened at the mid-diaphysis by percutaneous 
drilling with an 18-G needle. A small anteromedial skin inci-
sion was made proximal to the tibial tubercle and a 17-G can-
nula needle was inserted through the proximal metaphyseal 
cortex into the medullary canal as described previously (Li 
et al. 2004). The tibia was then fractured by manual 3-point 
bending and fixed in either 40° anterior angulation or straight 
alignment, which in both cases included the normal 13° ana-
tomical curve of the diaphysis. 
Radiography 
The  progress  of  fracture  healing  was  monitored  on  lateral 
radiographs under Hypnorm anesthesia on day 0, 7, 21, 35, 
and 56 after fracture (Figure 1A and B). The radiographic 
set-up was adjusted to result in size enhancement of the image 
by 33%. Callus size was then measured manually on a 300% 
magnified printout. The total callus size was assessed by mea-
suring the transverse diameter (in mm) of the callus and the 
thickness of cortical bone anterior and posterior to the nail at 
the level of the apex of the angulated needle.
Sampling
The rats were anesthetized with sodium pentobarbitone (60 
mg/kg, i.p.). 4 rats in each fracture group were killed on days 
3, 7, 21, 35, and 56, while the 4 control rats with intact tibias 
were killed on day 21. In vivo intra-aortic perfusion was car-
ried out with phosphate-buffered saline (PBS), followed by 
fixation with Zamboni’s buffered 4% paraformaldehyde solu-
tion containing 0.2% picric acid in 0.2 M Sörensen phosphate 
buffer, pH 7.2. The right tibia was dissected and then demin-
eralized  at  room  temperature  in  a  solution  containing  7% 
AlCl3, 5% formic acid, and 8.5% HCl for 12 h. The samples 
were soaked in 20% sucrose for at least 2 days. Each demin-
eralized tibia was divided sagittally in two halves and 2-cm 
long samples of the medial half of the tibial diaphysis, which 
included the proximal, middle, and distal parts of the healing 
fracture, were collected for analysis. Subsequently, the 2-cm 
long samples were sectioned at a thickness of 15 µm using 
a cryostat. Thus, the regions undergoing endochondral and 
intramembranous ossification were all included in the same 
section.
Immunohistochemistry
Serial sections were numbered consecutively from the middle 
to the medial aspect. Two-interval sections, i.e. one close to 
the middle part and another close to the medial part of the 
tibia at each time point, were chosen for H & E staining and 
for  immunostaining  according  to  the  biotin-avidin  system. 
Thus, the sections were hydrated in 0.01 M PBS for 10 min 
and then incubated with 10% normal goat serum at room tem-
perature for 30 min. Subsequently, the sections were incu-
bated at room temperature overnight in a humid atmosphere 
with polyclonal antibody to NPY (1:5,000; Peninsula Labo-
ratories, San Carlos, CA). After rinsing in PBS (2 × 5 min), 
Figure 1. Lateral view of tibia at day 0 
and day 35 postfracture, fixed in straight 
alignment  (A)  and  anterior  angulation 
(B).  The  broken  squares  in  the  X-ray 
images (panels A and B) depict the dis-
sected sample for microscopic analysis 
of  longitudinal  sections  shown  in  the 
schematic  illustration  (C).  The  small 
dotted  squares  in  the  drawing  of  the 
dissected sample represent the 8 micro-
scopic fields studied in each tissue sec-
tion for morphological and semi-quanti-
tative analysis of NPY immunoreactivity. 
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the sections were incubated with biotinylated goat anti-rabbit 
antibody (1:250; Vector Laboratories, Burlingame, CA) for 40 
min. Finally, fluorochrome Cy3-conjugated avidin (1:5,000; 
Amersham) was used for visualization of the immune reac-
tion. Control staining was performed by omitting the primary 
antibody. Addition of 50 µL of peptide to the correspond-
ing antiserum before application to tissue sections served as 
another control.
For double staining, after completing the staining step for 
NPY using fluorochrome Cy2-conjugated avidin for visualiza-
tion of the immunoreaction, the sections were incubated for 15 
min with avidin-blocking solution followed by biotin-block-
ing solution. The sections were then incubated with goat anti-
mouse monoclonal antibody to GAP-43 (1:2,000), a marker 
of axon growth, neuronal development, and nerve regenera-
tion, and mouse polyclonal antibody to PGP 9.5 (1:10,000; 
both  antibodies  from  Boehringer  Mannheim  Biochemicals, 
Germany), the marker for mature nerve fibers. Then the sec-
tions were incubated with biotinylated anti-mouse antibodies 
(1:250; Vector Laboratories) for 40 min. The fluorochrome 
Cy2-conjugated  avidin  (1:1000;  Amersham)  was  used  for 
visualization  of  the  immunoreaction.  An  epifluorescence 
microscope was used for analysis (20× objective). 
Semiquantification
The nerve fiber density in and adjacent to the fracture area 
during healing and modeling was quantified by computer-
ized image analysis as previously described (Li et al. 2007). 
Briefly, 2 consecutive tissue sections per rat were included. 
In each tissue section, 4 fields (20×) of each were selected in 
a standardized manner from the concave and convex sides, 
for comparison and quantification (Figure 1C). For quantifi-
cation by computerized image analysis, images of the tissue 
sections were captured by a video camera attached to the 
immunofluorescence microscope and then saved in a com-
puter. The fields selected were analyzed using Easy Analysis 
software (Bergström Instruments, Stockholm, Sweden). A 
standard lower and upper threshold of fluorescence intensity 
was consistently applied for positively stained nerve fibers. 
The results were expressed as the nerve fiber immunofluo-
rescent area in relation to the total area of each microscopic 
field. Since there were 2 tissue sections in each rat, 8 micro-
scopic fields representing the convex side and 8 other fields 
representing the concave side were analyzed. The mean value 
(the percentage of neuronal immunofluorescenc area) based 
on 8 microscopic fields was determined in 4 rats to obtain a 
measure of fiber density for comparison of the concave and 
convex sides of each tibia. 
Statistics 
For semiquantitative analysis of neuronal NPY-positive immu-
nofluorescence area, a non-parametric approach was used. In 
each experimental group, the statistical analysis was based on 
the mean of the values from 4 rats at each time point. Since our 
data was skewed, the results are presented as mean, median, 
and range (minimum and maximum). Mean values were used 
to  calculate  the  fold  differences  in  NPY  immunoreactivity 
whereas median values were used to obtain the statistically 
significant differences between the sides. To compare the dif-
ferences between the convex and concave sides within the 
same group, the Wilcoxon test was used. A p-value of < 0.05 
was considered statistically significant.
Results
Radiography
Radiographic  analysis  showed  a  statistically  significant 
increase in total callus formation from day 0 to day 21 post-
fracture (inflammatory and proliferative phases) in both frac-
ture groups. When compared to the bone thickness of each side 
at day 0, the angular fracture exhibited a 3.5- fold increase in 
callus thickness on the concave side, whereas only a 0.2-fold 
increase in callus thickness was observed on the convex side at 
day 21 (p = 0.03). During the remodeling phase, i.e. between 
day 21 and day 56, a 0.2-fold reduction in callus thickness 
was observed on the convex side (p = 0.05), while the callus 
thickness remained almost the same on the concave side, as 
compared to day 21. In the straight fracture, an almost equal 
increase in callus thickness was observed on the concave side 
(1.9-fold) and on the convex side (1.1-fold), reaching a peak 
at day 21. It then decreased gradually, in a similar way on both 
sides. 
Histology 
The longitudinal sections of tibia were stained with H & E at 
7, 21, and 35 days postfracture in both fracture groups (Figure 
2).  In  the  straight  fracture,  a  similar  histological  picture 
depicting different phases of bone repair was seen on the two 
sides of the fracture. Thus, there were equal amounts of new 
woven bone and callus formation at day 7, complete thickened 
cortical bridging at day 21, and reduction in cortical size with 
normal bone architecture at day 35. However, in the angular 
fracture a different histological picture was seen, with dispar-
ity in bone repair between the concave and the convex sides. 
The increase in the size of new woven bone and callus forma-
tion was greater on the concave side than on the convex side 
at day 7 (Figure 2A and B). At day 21, cortical bridging was 
complete with periosteal hypertrophy and intense new bone 
formation on the concave side, whereas these changes were 
much less apparent on the convex side (Figure 2C and D). At 
day 35, a further reduction in cortical thickness was observed 
on the convex side whereas it remained the same on the con-
cave side, representing normal bone architecture (Figure 2E 
and F). The morphological changes representing callus thick-
ness between the concave and convex sides were based on 
observations in 4 rats at each time point (Figure 2A and F).642  Acta Orthopaedica 2010; 81 (5): 639–646
Distribution of NPY nerve fibers in fractures 
NPY-positive nerve fibers were identified in the intact tibia 
and at the fracture site in both straight and angular fractures at 
all time points of the study.
In angulated fractures, ingrowth of nerve fibers containing 
NPY was already observed at day 3 postfracture in the frac-
ture hematoma arranged as non-vascular nerve fibers (Figure 
3A and B). At day 7, an increased number of NPY-positive 
fibers was found on the concave side compared to the convex 
side. These nerve fibers were seen as fibers sprouting into the 
fibrocartilage callus from the deep layers of the periosteum. 
Many  fibers  were  seen  close  to  the  chondroid  cells,  and 
Figure 2. Hematoxylin and eosin (H & E) staining (A-F) showing changes in bone thickness on the convex 
(anterior) side (A, C, and E) and the concave (posterior) side (B, D, and F) of the angulated fracture at day 7 
(A and B), 21 (C and D), and 35 (E and F) after fracture. The arrows depict the thickness of woven bone or 
new bone, showing intensive bone formation on the concave side at early phases of fracture healing (days 7 
and 21) and intense reduction of bone thickness on the convex side at a later phase of fracture healing (day 
35). The small dotted square in each panel depicts the observed area of NPY immunostaining (20×) shown 
specifically in Figures 4 and 5. 2× objective. Bar represents 1,000 μm. CA: cartilaginous callus; CO: cortical 
bone; FG: fracture gap; NB: new bone; PE: periosteum; WB: woven bone. 
Figure 3. Fluorescence photomicrographs showing site-specific occurrence of 
NPY fibers on the convex (A and C) and concave (B and D) sides of angulation 
fractures at days 3 (A and B) and 7 (C and D) after fracture. 20× objective. Bar 
represents 50 μm. Arrows show NPY fibers. HE: hematoma; MU: muscle; PE: 
periosteum; WB: woven bone.
Figure 4. Fluorescence photomicrographs showing site-specific occurrence of 
NPY fibers on the convex (A and C) and concave (B and D) sides of angulation 
fractures at days 21 (A and B) and 35 (C and D) after fracture. 20× objective. 
Bar represents 50 μm. Arrows show NPY fibers. NB: new bone; MU: muscle; 
PE: periosteum; VE: vessel; WB: woven bone.Acta Orthopaedica 2010; 81 (5): 639–646  643
they had entered the new-woven bone (Figure 3C and D). 
Between days 21 and 35, NPY-positive fibers were mainly 
observed as networks in and around the walls of blood ves-
sels, both in the deeper layers of hypotrophic periosteum and 
in the new bone on the concave side, whereas few vascular 
fibers entering into new bone were found on the convex side 
(Figure 4A and B). At day 56 postfracture, during the remod-
eling, most of the NPY-positive fibers were seen retracted 
from the fracture site and were present as vascular fibers in 
the periosteum.
In  straight  fractures,  the  occurrence  and  distribution  of 
NPY-positive fibers over the time period was similar to that 
seen in the angular fracture, with one notable difference. An 
increased number of NPY-positive fibers with similar amount 
were seen penetrating the woven bone on both sides of the 
fracture at day 7. No side-specific differences in expression 
were found over time.
Double-staining  experiments  showed  that  there  was  co-
expression of GAP 43, a marker of regenerating nerve fibers, 
with NPY-positive fibers at the fracture site in both groups 
at all time points. The co-localization of GAP 43 with NPY 
was more intense between days 3 and 21 postfracture than that 
at the later time periods (Figure 5A and C). Double-staining 
studies of PGP 9.5, a neuronal marker of mature nerve fibers 
and NPY showed a co-localization that was less obvious at 
days 3–21, but which became more pronounced at days 35–56 
postfracture (Figure 5B and D).
Semiquantitative analysis of NPY innervation
In general, there was a statistically significant increase in the 
number of nerve fibers expressing NPY at the fracture site in 
both straight and angular fractures at days 7, 21, and 35 post-
fracture as compared to intact tibia (Table). 
In angular fractures, a 5-fold increase in NPY-immunore-
active fibers was seen on the concave side as compared to the 
convex side when comparison was made with the innerva-
tion of intact bone at day 7. Notably, a statistically signifi-
cant (6-fold) increase in NPY-positive fibers was seen on the 
convex side between days 21 and 56, whereas the correspond-
ing increase in NPY was only 0.1-fold on the concave side 
during the same time period, when compared to day 7 (Table). 
Interestingly, the peak in NPY-positive fibers was only seen 
on the convex side in the angular fractures at days 21 and 35. 
Although the amount of NPY-positive fibers was similar on 
the concave and convex sides in the angular fractures between 
days 21 and 56, an increase in NPY innervation on the convex 
side was observed, but it was not statistically significant.
Figure 5. Fluorescence photomicrographs showing double staining of NPY and 
GAP-43 (A and C) or PGP 9.5 (B and D) at the fracture site in angulation frac-
tures at days 7 (A and B) and 56 (C and D) after fracture. Co-localization of 
NPY (red) with GAP-43 (green) and with PGP 9.5 (green), resulting in yellow 
color, as seen in the woven bone and hypertrophic periosteum (A) and con-
nective tissue (B) at day 7 and vessels (C and D) at day 56. 20× objective. Bar 
represents 50 μm. Arrows show co-localization of NPY with GAP-43 or with 
PGP 9.5. CN: connective tissue; MU: muscle; PE: periosteum; VE: vessel; WB: 
woven bone.
Changes of NPY immunoreactivity in straight and angulated fractures
  Straight fracture  Angulated fracture 
  Posterior side  Anterior side  Posterior (concave) side  Anterior (convex) side 
Day  A  B  C  A  B  C  D  A  B  C  A  B  C  D
  3  –0.07  –0.15  –0.28–0.29  –0.17  –0.26  –0.33–0.17  0.1   0.11  –0.16  –0.47–1.21  –0.18  –0.38  –0.60–0.70  0.4 
  7  0.45  0.39    0.09–0.92  0.22  0.10  –0.16–0.85  0.5  0.50  0.53    0.35–0.61  –0.51  –0.53  –0.62 to –0.35  0.04
21  0.44  0.44  –0.04–0.91  0.60  0.45    0.17–1.33  0.7   0.67  0.67    0.67–0.67  0.86  0.66    0.54–1.39  0.9
35  0.85  0.54    0.08–2.22  0.70  0.39    0.07–1.97  0.1  0.52  0.45    0.21–0.98  0.75  0.67    0.48–1.18  0.8
56   0.01  0.06  –0.40–0.34  –0.07  –0.21  –0.57–0.69  0.5  0.16  0.15    0.06–0.29  0.04  0.06  –0.06–0.10  0.1
The percentage changes of NPY immunoreactivity in both straight fracture and angulated fracture at each time point as compared to intact (control) bone. 
A  Mean
B  Median 
C  Range 
D  P-value644  Acta Orthopaedica 2010; 81 (5): 639–646
In the straight fractures, a statistically significant increase 
in NPY-positive fibers was found both on the concave side 
(by a factor of 0.6) and on the convex side (by a factor of 
0.4) when compared to intact tibia at day 7. The maximum 
increase in NPY-positive fibers (by a factor of 1) was observed 
on both sides in the straight fractures at day 35, the phase of 
bone remodeling. Later, the density of NPY fibers returned to 
the normal (intact) level on both sides of the fracture (Table). 
Discussion
Our study demonstrates temporal and side-specific changes in 
NPY innervation during the early and the late phase of angular 
fracture healing. The early increase in NPY innervation seen 
on the bone-forming concave side during the inflammatory 
phase may be a response to injury with the possible stimula-
tory effects on cell proliferation and angiogenesis leading to 
enhanced bone formation. The increased expression of NPY 
seen on the convex (bone resorption) side during the remod-
eling phase appears to coincide with the reduction in callus 
thickness. The later increase in NPY expression on the convex 
side may reflect the role of NPY in bone resorption, possibly 
through the Y1 receptor. Given the proposed central role of 
NPY in bone homeostasis, our results suggest that NPY may 
have a peripheral neuronal function in local bone turnover, 
especially during fracture healing and correction of angular 
deformity.
The early inflammatory phase of fracture healing lays the 
foundation for bone healing as inflammatory cells secrete a 
number  of  proinflammatory  cytokines  with  bone  induction 
properties. Accordingly, the cascade of reparative processes 
such as matrix synthesis, cell proliferation, angiogenesis, and 
neurogenesis is induced. Our results show an intense but simi-
lar pattern of nerve regeneration containing autonomic neu-
ropeptide NPY in the fracture callus and woven bone on the 
two sides of a straight fracture (Figures 3 and 5). However, 
in an angular fracture this phenomenon of nerve regenera-
tion was observed mainly on the concave side (Figure 3B and 
D) (Table). The regenerative nature of NPY immunoreactive 
fibers observed in the inflammatory phase of fracture healing 
was confirmed by identification of co-expression of GAP-43, 
a neuronal marker of nerve regeneration, in the NPY-positive 
fibers (Figure 5). It is presumed that increased delivery of 
NPY from the nerve endings during the inflammatory phase 
of fracture healing would exert a beneficial effect on bone 
repair by modulating various cellular events. A number of 
studies have suggested that NPY exerts a strong angiogenic 
effect, mainly on the Y2 receptor (Y2R) (Ekstrand et al. 2003, 
Lee et al. 2003). In vitro studies have shown that NPY pro-
motes  vessel  sprouting  and  adhesion,  migration,  prolifera-
tion, and capillary tube formation in human endothelial cells 
(Zukowska-Grojec et al. 1998, Movafagh et al. 2006). Fur-
thermore, it has been shown that vessel sprouting is reduced 
to 50% after deleting Y2R or by using antagonists of Y2R 
(Lee et al. 2003). In addition, a delay in skin wound healing 
and reduced neovascularization was observed in mice lacking 
Y2R (Ekstrand et al. 2003). It is known that early angiogen-
esis at the fracture site is one of the most important parameters 
influencing the healing process (Keramaris et al. 2008). Our 
study has shown early proliferation of nerve fibers containing 
NPY at the fracture site where increased callus formation is 
observed (concave side in angular fractures and on both sides 
in straight fractures), which possibly contributes to the heal-
ing process by stimulating angiogenesis (Figure 3 and 5). In 
addition to angiogenesis, recent studies have shown a possible 
role of NPY in neurogenesis. A potential role of NPY in the 
survival and the regenerative process of neurons was indicated 
by the dramatic increase in NPY expression in dorsal root 
ganglia after peripheral nerve injury (Wakisaka et al. 1991). 
Moreover, a possible proliferative effect of NPY on neuro-
blasts in different areas of the neonatal and adult brain has 
been shown to be mediated mainly through Y1R (Howell et al. 
2003, 2005). In addition to the CNS, NPY has also been iden-
tified as a neurotrophic factor in the peripheral nervous system 
by  showing  its  regenerative  effect  on  olfactory  epithelium 
(Hansel et al. 2001, Hökfelt et al. 2008). It has been shown 
that NPY acting through Y1R stimulates the proliferation of 
adult olfactory neuroblasts. Conversely, NPY-deficient mice 
were found to show a significant reduction in olfactory neuro-
nal precursor cell proliferation (Hansel et al. 2001). Recently, 
it has been shown that increased release of NPY promotes the 
regeneration of damaged olfactory sensory neurons (Kanekar 
et al. 2009). Altogether, the role of NPY implicated in neu-
roangiogenesis might set up the initial framework for a satis-
factory bone-healing process. 
We have recently established a rat model of angular frac-
ture of the tibia, which covers not only the healing process 
but  also  the  subsequent  bone  remodeling  (Li  et  al.  2004, 
2007). In these studies, angulation gave a clear-cut difference 
in local bone turnover between the concave and convex sides 
of the fracture. We also found intense bone formation on the 
concave side whereas bone resorption predominated on the 
convex side, both sides thereby contributing to spontaneous 
correction of the angular deformity (Figure 1 and 2). Notably, 
our angular fracture model also permits sequential analysis 
of local mediators involved in bone formation and resorp-
tion within well-defined areas of the same bone at different 
stages of fracture healing. Thus, we have observed increased 
expression of the sensory neuropeptide CGRP on the concave 
side,  where  intense  new  bone  formation  occurred.  On  the 
convex side where bone resorption predominated, there was 
an increase in the occurrence of the bone resorption cytokine 
interleukin-1 (Li et al. 2004, 2007), as confirmed by others 
(Gordon et al. 2008).
In the present study a reduction in callus thickness during 
the remodeling phase which coincided with a 6-fold increase 
in NPY expression on the convex side, probably highlights Acta Orthopaedica 2010; 81 (5): 639–646  645
the role of NPY in bone resorption. Even though there is no 
conclusive  evidence  to  implicate  NPY-mediated  signaling 
in bone homeostasis, a number of studies have indicated the 
probable role of NPY in local bone turnover through the cen-
tral and peripheral nervous system (Baldock et al. 2002, 2007, 
Lundberg et al. 2007). Recent studies analyzing germ line or 
conditional knockout mice lacking Y2R have revealed that the   
osteoblast activity is controlled by a central pathway through 
hypothalamus. These studies have shown an increased rate of 
bone mineralization and elevated bone mass due to increased 
osteoblast activity in Y2R knockout mice (Lundberg et al. 
2007). However, the presence of neuronal NPY in high osteo-
genic areas such as the periosteum, epiphysis growth plate, 
and bone marrow may suggest a role of NPY in local bone 
turnover by a peripheral pathway (Bjurholm et al. 1988, Hill 
and Elde 1991). Recently, the Y1 receptor was reported to be 
present in human osteoblastic and osteosarcoma-derived cell 
lines (Lundberg et al. 2007), and treatment of wild-type mice 
with NPY caused reduction in bone mass and volume (Ducy 
et al. 2000). In addition, in vitro studies have demonstrated 
that NPY can inhibit the osteoblastic parathyroid hormone 
response through a receptor-receptor interaction (Bjurholm et 
al. 1992). A more direct effect of NPY on bone cells involved 
in bone remodeling has been reported. Not only the presence 
of Y1R on osteoblasts but also a generalized increase in bone 
formation on the cortical and cancellous surfaces of bone has 
been shown in Y1R-deleted mice (Lundberg et al. 2007). It 
can be assumed that the elevated levels of NPY seen in our 
study caused an overstimulation of Y1R on osteoblasts, lead-
ing to bone resorption on the convex side of the fracture. 
In summary, we have demonstrated upregulation in neu-
ronal expression of NPY during the early and late phases of 
angular  fracture  healing,  thus  highlighting  a  probable  role 
of NPY in local bone remodeling. The findings of this study 
combined with those in previous reports suggest that NPY 
may  play  a  role  in  the  regulation  of  skeletal  homeostasis, 
probably through Y1R. Therapeutic application of the NPY 
system has emerged as a promising area of research in clini-
cal orthopedics. A useful approach in this regard would be the 
anti-ligand/anti-receptor strategy to prevent or minimize bone 
loss in a number of skeletal disorders such as tumor, trauma, 
and infection.
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